M3 Global Research combines MDLinx and EMS to offer online access to 1.3 million healthcare professionals
Washington, DC, November 22, 2010 – M3 USA, parent company of MDLinx, a leading medical market research firm, has signed an agreement to purchase EU-based EMS Research, a company specializing in quantitative and qualitative market research for clients in healthcare and other vertical markets.
The acquisition creates the largest verified provider of physicians and other healthcare professionals in the world. This new international division will be designated M3 Global Research. With offices in the US, UK, Germany, Japan, Korea and China, M3 Global Research will offer access to 1.3 million verified doctors and other healthcare professionals, differentiated into more than 700 subspecialties.
M3 Global Research will provide the highest standard of direct access, utilizing its proprietary physician panels, online survey tools, call centers, fieldwork studios, and in-house project managers in offices around the world.
“EMS Research has always prided itself on our superior market research capabilities. By teaming with M3, we have greatly expanded the depth and breadth of our abilities on a global perspective,” said Neil Jarvis, Director at EMS.
“Europe was the missing component in our market research global coverage strategy. The EMS acquisition firmly secures our place as the healthcare market research industry leader, and equips us with the largest verified panel of healthcare professionals in the world,” said Aki Tomaru, CEO of M3 USA. “Our clients will now enjoy unparalleled global reach as they gather insights from healthcare professionals and experience our best-in-industry, single source service.”
M3 Global Research and M3 USA
M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professional panel of 1.3 million respondents in more than 60 countries. The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research in Europe, and M3 companies across Asia. M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers. M3 has provided solutions for every top 20 pharmaceutical company in the world. For more information, visithttp://research.m3.com or email requests to email@example.com.
EMS Research, headquartered in London, England, was founded in 1999 and is Europe’s leading in-house medical fieldwork company. M3 Global Research will maintain EMS’s unparalleled research quality at competitive cost via effective management and expansion of research assets across Europe, including respondent databases, pan-European project teams, in-house moderators, online survey tools, call centers, field teams and viewing facilities.
Greg Jones for M3 Global Research